• Vertex Pharmaceuticals average return on tangible equity for 2023 was 26.51, a 16.19% decline from 2022.
• Vertex Pharmaceuticals average return on tangible equity for 2022 was 31.63, a 1.77% decline from 2021.
• Vertex Pharmaceuticals average return on tangible equity for 2021 was 31.08, a 23.18% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.